US 6696407
Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF
expired A61KA61K31/00A61K31/198
Quick answer
US patent 6696407 (Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF) held by The Regents of the University of California expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/00, A61K31/198, A61K31/502